NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2023
Back to search
Official data from USPTO
GENECENTRIC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
09/12/2023
Trademark type
Word
Nice classes
44
Filing date
08/09/2021
Registration date
09/12/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/12/2023
Last transaction
09/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2011-06-00
First use in commerce
2011-06-00
Drawing code
4
Owner type
03
Owner location
Durham, NC
Examiner
HAYNES,SAMANTHA M
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GENECENTRIC THERAPEUTICS, INC.
Representatives
Devon E. White WYRICK ROBBINS YATES & PONTON LLP
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
medical services; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; providing patient medical record information and patient reports based thereon to physicians; providing information to physicians and patients regarding medical diagnostic tests that will help them make better health care decisions; medical information services; medical information servicesreporting of testing results directly to patients
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/09/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/08/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/07/2023
EX2G
SOU EXTENSION 2 GRANTED
08/07/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/07/2023
IUAF
USE AMENDMENT FILED
07/26/2023
EXT2
SOU EXTENSION 2 FILED
07/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/26/2023
EISU
TEAS STATEMENT OF USE RECEIVED
07/26/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/08/2023
EX1G
SOU EXTENSION 1 GRANTED
02/06/2023
EXT1
SOU EXTENSION 1 FILED
02/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2022
PUBO
PUBLISHED FOR OPPOSITION
06/14/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2022
DOCK
ASSIGNED TO EXAMINER
05/09/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/01/2021
NWAP
NEW APPLICATION ENTERED
08/12/2021
Continuous trademark protection
Get notified about every new filing that threatens GENECENTRIC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.